ACTRN12621001492842
Not yet recruiting
未知
Profiling the immune response to COVID-19 vaccination in vulnerable populations (COVULPOP).
Prof Katie Flanagan0 sites40 target enrollmentNovember 2, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- COVID-19 vaccine response
- Sponsor
- Prof Katie Flanagan
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Younger adults: aged 18 to 45 years, healthy with no major co\-morbidities .
- •Elderly: 65 years of age or older with or without co\-morbidities.
- •Pregnant women: healthy uncomplicated pregnancy at any stage of gestation
- •All participants:
- •\- Ability to communicate in English
- •\- Ability to communicate by mobile telephone and text messaging
- •\- Written informed consent to participate in the trial
Exclusion Criteria
- •\- Outside the specified age range
- •\- Inability to speak and/or understand English
- •\- Diagnosed with a cognitive impairment or inability to provide informed consent
- •\- Known allergy or contraindication to COVID\-19 (or dTap or influenza vaccination in pregnant women)
- •\- Unwilling to give consent to participate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Immune response to COVID-19 Vaccination in people with Diabetes MellitusType 1 Diabetes MellitusType 2 Diabetes MellitusTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2021-001459-15-ATMedical University of Graz161
Recruiting
Not Applicable
Evaluation of the immune response against COVID-19 in pediatric Cancer patients after vaccinatioeed for vaccination against COVID-19C91C92Lymphoid leukaemiaMyeloid leukaemiaDRKS00025254Pädiatrische Hämatologie und OnkologieKlinik für Kinder- und JugendmedizinJohann Wolfgang Goethe Universität100
Recruiting
Not Applicable
EVEREST: Evaluation of COVID-19 Vaccination Efficacy and Rare Events in Solid TumoursACTRN12621001307897The Canberra Hospital200
Recruiting
Phase 4
Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune diseaseRheumatoid arthritisPsoriatic arthritisAnkylosing spondylitisCrohn's DiseaseUlcerative ColitisCOVID-19Inflammatory bowel diseaseInflammatory and Immune System - Autoimmune diseasesOral and Gastrointestinal - Crohn's diseaseOral and Gastrointestinal - Inflammatory bowel diseaseMusculoskeletal - Other muscular and skeletal disordersInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersInflammatory and Immune System - Rheumatoid arthritisACTRN12621000661875Dr Ai Tran100
Not yet recruiting
Not Applicable
COVID-19 VaccinAtion in patients with chronic Kidney disease in New Zealand (C-VAK NZ study)Kidney TransplantDialysisCovid-19Renal and Urogenital - Kidney diseaseInfection - Other infectious diseasesACTRN12621000460808Auckland District Health Board600